Essential Medicines for Universal Health Coverage

7 November 2016

Policy

Medicines for Europe’s Contribution to WHO’s Biological Qualifier (BQ) Developments (PRESENTATION and SPEECH)

18 October 2016

Policy

      18 October 2016 Suzette Kox Senior Director […]

Simon-Kucher. Policy Requirements for a Sustainable Biosimilar Market (September 2016)

19 September 2016

Report

Rebranding Medicines for Europe

16 June 2016

Video

Understanding the Science of Extrapolation and Defining Interchangeability – Dr. Elena Wolff-Holz, EULAR Symposium London

10 June 2016

Policy

IMS – The Impact of Biosimilar Competition (2016)

1 June 2016

Report

Value Added Medicines: Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access

31 May 2016

Policy, Report

Factsheet: About The Value Added Medicines Group

31 May 2016

Factsheet

Factsheet: What is a Value Added Medicine

31 May 2016

Factsheet

Infographic: Rethink, Reinvent & Optimise Medicines, Improving Patient Health & Access

31 May 2016

Infographic